UNSPSC 85703518: Revision of autologous tissue substitute in right tibia, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in right tibia, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QWG37Z

UNSPSC 85703518 Revision of autologous tissue substitute in right tibia, percutaneous approach is a Commodity code that shows little relevant recent activity. The code nominally describes a surgical orthopedic procedure, but the recent opportunities posted under it are administrative health services, pharmacy benefits management, occupational medical surveillance, and temporary clinical staffing — none of which align with tissue revision or orthopedic surgery. The Phoenix Retirement Office, City of Long Beach, Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County, and Santa Clara County Health System have all tagged unrelated services to this code, suggesting either systematic miscoding in state and local procurement systems or the code's use as a catch-all for medical services generally. This mismatch renders the code unreliable as a signal of actual orthopedic device or tissue-substitute procurement activity.

The recent opportunities do reflect diverse health-sector issuing bodies — municipal retirement offices, county human resources departments, state transportation agencies, juvenile detention systems, and regional health systems — but none address the scope the code nominally describes. Without opportunities genuinely aligned to tissue-substitute revision, autologous graft services, or related orthopedic device procurement, the code does not present a decision-relevant signal for business development professionals targeting state and local orthopedic or surgical-materials supply chains. Practitioners should monitor higher-tier codes in the medical devices and supplies families or track opportunities through health-system RFP channels directly rather than rely on this Commodity classification.